8-K Announcements
6Material company update
Apr 1, 2026·SEC
Material company update
Feb 26, 2026·SEC
Material company update
Jan 12, 2026·SEC
Natera, Inc.(NTRA)Earnings, Financials & Key Ratios
NTRA•NASDAQ
$215.09
$29.58B mkt cap·Price updated May 6, 2026
AboutNatera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.Show more
- Revenue$1.7B+56.7%
- EBITDA-$191M+53.1%
- Net Income-$190M+56.2%
- EPS (Diluted)-1.53+59.5%
- Gross Margin60.3%+32.5%
- EBITDA Margin-11.28%+70.1%
- Operating Margin-13.1%+68.2%
- Net Margin-11.22%+72.1%
- ROE-19.42%+67.1%
- ROIC-33.27%+37.8%
- Debt/Equity0.16-72.9%
- Interest Coverage-20.80+41.1%
NTRA Key Insights
Natera, Inc. (NTRA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 41.2%
- ✓Efficient asset utilization: 1.0x turnover
✗Weaknesses
- ✗Expensive at 22.4x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
NTRA Price & Volume
Natera, Inc. (NTRA) stock price & volume — 10-year historical chart
Loading chart...
NTRA Growth Metrics
Natera, Inc. (NTRA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years26.69%
5 Years41.2%
3 Years39.47%
TTM38.17%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-44.02%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-29.38%
Return on Capital
10 Years-55.78%
5 Years-40.29%
3 Years-36.62%
Last Year-18.14%
NTRA Recent Earnings
Natera, Inc. (NTRA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 12/12 qtrs (100%)
Q1 2026Latest
Feb 26, 2026EPS
$0.35
Est $0.51
+168.3%
Revenue
$666M
Est $604M
+10.2%
Q4 2025
Nov 6, 2025EPS
$0.64
Est $0.39
-65.9%
Revenue
$592M
Est $513M
+15.3%
Q3 2025
Aug 7, 2025EPS
$0.74
Est $0.62
-20.2%
Revenue
$547M
Est $476M
+14.8%
Q2 2025
May 8, 2025EPS
$0.50
Est $0.64
+21.9%
Revenue
$502M
Est $446M
+12.5%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 26, 2026 | $0.35vs $0.51+168.3% | $666Mvs $604M+10.2% |
| Q4 2025 | Nov 6, 2025 | $0.64vs $0.39-65.9% | $592Mvs $513M+15.3% |
| Q3 2025 | Aug 7, 2025 | $0.74vs $0.62-20.2% | $547Mvs $476M+14.8% |
| Q2 2025 | May 8, 2025 | $0.50vs $0.64+21.9% | $502Mvs $446M+12.5% |
Based on last 12 quarters of dataView full earnings history →
NTRA Peer Comparison
Natera, Inc. (NTRA) competitors in Molecular and Genetic Diagnostics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 ILMN | 21.66B | 142.58 | 26.16 | -0.78% | 19.43% | 32.84% | 0.94 | |
 CGEN | 247.13M | 2.76 | -17.25 | -16.72% | -5.77% | -71.54% | 0.05 | |
 MYRG | 7.08B | 454.78 | 60.40 | 8.79% | 3.71% | 22.14% | 0.16 | |
 PACB | 516.17M | 1.71 | -1.60 | -23.19% | -325.8% | -13.95% | 1.33 | |
 PRME | 615.68M | 3.41 | -2.53 | 55.28% | -43.42% | -178.61% | 0.96 | |
 CDNA | 1.08B | 20.94 | -52.35 | 13.79% | -1.98% | -2.61% | 0.06 | |
 TMO | 175.76B | 472.95 | 26.66 | 3.91% | 15.18% | 13.23% | 0.76 |
Compare NTRA vs Peers
Natera, Inc. (NTRA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NTRA Income Statement
Natera, Inc. (NTRA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 217.07M | 210.94M | 257.65M | 302.33M | 391M | 625.49M | 820.22M | 1.08B | 1.7B | 2.12B |
| Revenue Growth % | 14.04% | -2.83% | 22.15% | 17.34% | 29.33% | 59.97% | 31.13% | 31.99% | 56.75% | 38.17% |
| Cost of Goods Sold | 135.57M | 139.6M | 166.06M | 175.47M | 203.62M | 318.42M | 456.26M | 589.83M | 673.75M | 768.37M |
| COGS % of Revenue | 62.46% | 66.18% | 64.45% | 58.04% | 52.08% | 50.91% | 55.63% | 54.48% | 39.7% | - |
| Gross Profit | 81.5M▲ 0% | 71.34M▼ 12.5% | 91.6M▲ 28.4% | 126.86M▲ 38.5% | 187.38M▲ 47.7% | 307.07M▲ 63.9% | 363.97M▲ 18.5% | 492.74M▲ 35.4% | 1.02B▲ 107.6% | 1.35B▲ 0% |
| Gross Margin % | 37.54% | 33.82% | 35.55% | 41.96% | 47.92% | 49.09% | 44.37% | 45.52% | 60.3% | 63.7% |
| Gross Profit Growth % | 5.15% | -12.46% | 28.39% | 38.49% | 47.71% | 63.87% | 18.53% | 35.38% | 107.65% | - |
| Operating Expenses | 177.99M | 205.37M | 206.23M | 243.15M | 403.66M | 775.24M | 905.01M | 938.99M | 1.25B | 1.7B |
| OpEx % of Revenue | 81.99% | 97.36% | 80.04% | 80.42% | 103.24% | 123.94% | 110.34% | 86.74% | 73.4% | - |
| Selling, General & Admin | 136.13M | 155.31M | 154.87M | 206.18M | 303.63M | 511.03M | 588.59M | 618.31M | 841.31M | 1.12B |
| SG&A % of Revenue | 62.71% | 73.63% | 60.11% | 68.2% | 77.65% | 81.7% | 71.76% | 57.11% | 49.58% | - |
| Research & Development | 41.86M | 50.06M | 51.35M | 51.36M | 100.03M | 264.21M | 316.42M | 320.68M | 404.14M | 578.38M |
| R&D % of Revenue | 19.28% | 23.73% | 19.93% | 16.99% | 25.58% | 42.24% | 38.58% | 29.62% | 23.82% | - |
| Other Operating Expenses | 0 | 0 | 0 | -14.39M | 0 | 0 | 0 | 0 | 0 | 917K |
| Operating Income | -96.49M▲ 0% | -134.03M▼ 38.9% | -114.63M▲ 14.5% | -116.29M▼ 1.4% | -216.28M▼ 86.0% | -468.17M▼ 116.5% | -541.04M▼ 15.6% | -446.25M▲ 17.5% | -222.29M▲ 50.2% | -351.87M▲ 0% |
| Operating Margin % | -44.45% | -63.54% | -44.49% | -38.46% | -55.31% | -74.85% | -65.96% | -41.22% | -13.1% | -16.62% |
| Operating Income Growth % | -61.25% | -38.91% | 14.47% | -1.45% | -85.99% | -116.47% | -15.56% | 17.52% | 50.19% | - |
| EBITDA | -90.31M | -126.88M | -107.13M | -108.56M | -207.66M | -456.92M | -510.57M | -407.63M | -191.33M | -315.12M |
| EBITDA Margin % | -41.6% | -60.15% | -41.58% | -35.91% | -53.11% | -73.05% | -62.25% | -37.65% | -11.28% | -14.89% |
| EBITDA Growth % | -66.31% | -40.5% | 15.57% | -1.33% | -91.29% | -120.03% | -11.74% | 20.16% | 53.06% | -53.79% |
| D&A (Non-Cash Add-back) | 6.18M | 7.14M | 7.5M | 7.73M | 8.61M | 11.25M | 30.47M | 38.62M | 30.97M | 36.74M |
| EBIT | -99.65M | -132.96M | -114.63M | -112.14M | -214.56M | -462.79M | -537.5M | -421.89M | -179.05M | -305.52M |
| Net Interest Income | 865K | -1.83M | -13.21M | -6.54M | -7.52M | -2.92M | -5.78M | 11.71M | 32.56M | 30.69M |
| Interest Income | 1.4M | 2.38M | 0 | 4.15M | 7.56M | 5.38M | 3.54M | 24.35M | 43.25M | 35.06M |
| Interest Expense | 533K | 4.21M | 10.48M | 10.69M | 15.08M | 8.3M | 9.32M | 12.64M | 10.69M | 4.37M |
| Other Income/Expense | 865K | -1.83M | -13.21M | -6.54M | -13.37M | -2.92M | -5.78M | 11.71M | 32.56M | 41.98M |
| Pretax Income | -95.62M▲ 0% | -135.86M▼ 42.1% | -127.83M▲ 5.9% | -122.83M▲ 3.9% | -229.65M▼ 87.0% | -471.1M▼ 105.1% | -546.82M▼ 16.1% | -434.53M▲ 20.5% | -189.73M▲ 56.3% | -309.89M▲ 0% |
| Pretax Margin % | -44.05% | -64.41% | -49.61% | -40.63% | -58.73% | -75.32% | -66.67% | -40.14% | -11.18% | -14.64% |
| Income Tax | 142K | 454K | 321K | 2M | 98K | 618K | 978K | 271K | 695K | -700K |
| Effective Tax Rate % | -0.15% | -0.33% | -0.25% | -1.63% | -0.04% | -0.13% | -0.18% | -0.06% | -0.37% | 0.23% |
| Net Income | -95.77M▲ 0% | -136.31M▼ 42.3% | -128.15M▲ 6.0% | -124.83M▲ 2.6% | -229.74M▼ 84.0% | -471.72M▼ 105.3% | -547.8M▼ 16.1% | -434.8M▲ 20.6% | -190.43M▲ 56.2% | -309.19M▲ 0% |
| Net Margin % | -44.12% | -64.62% | -49.74% | -41.29% | -58.76% | -75.42% | -66.79% | -40.16% | -11.22% | -14.61% |
| Net Income Growth % | -36.27% | -42.34% | 5.99% | 2.6% | -84.05% | -105.32% | -16.13% | 20.63% | 56.2% | -44.02% |
| Net Income (Continuing) | -95.77M | -137.63M | -128.15M | -124.83M | -229.74M | -471.72M | -547.8M | -434.8M | -190.43M | -309.19M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.86▲ 0% | -2.54▼ 36.6% | -2.22▲ 12.6% | -1.79▲ 19.4% | -2.84▼ 58.7% | -5.21▼ 83.5% | -5.57▼ 6.9% | -3.78▲ 32.1% | -1.53▲ 59.5% | -2.25▲ 0% |
| EPS Growth % | -26.53% | -36.56% | 12.6% | 19.37% | -58.66% | -83.45% | -6.91% | 32.14% | 59.52% | -29.38% |
| EPS (Basic) | -1.86 | -2.56 | -2.22 | -1.79 | -2.84 | -5.21 | -5.57 | -3.78 | -1.53 | - |
| Diluted Shares Outstanding | 51.58M | 53.6M | 57.85M | 69.56M | 81.01M | 90.56M | 98.41M | 115M | 124.72M | 137.19M |
| Basic Shares Outstanding | 51.45M | 53.31M | 57.73M | 69.56M | 81.01M | 90.56M | 98.41M | 115M | 124.72M | 137.19M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
NTRA Balance Sheet
Natera, Inc. (NTRA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 174.12M | 180.63M | 240.52M | 523.17M | 862.66M | 1.09B | 1.21B | 1.26B | 1.38B | 1.45B |
| Cash & Short-Term Investments | 146.12M | 118.87M | 153.87M | 440.99M | 737.27M | 914.28M | 898.39M | 878.98M | 968.28M | 1.04B |
| Cash Only | 15.26M | 12.62M | 46.41M | 61.93M | 48.67M | 84.39M | 466.09M | 642.1M | 945.59M | 1.04B |
| Short-Term Investments | 130.86M | 106.25M | 107.46M | 379.06M | 688.61M | 829.9M | 432.3M | 236.88M | 22.69M | 1M |
| Accounts Receivable | 13.4M | 44.09M | 62.22M | 53.35M | 78.56M | 122.07M | 244.38M | 278.29M | 314.17M | 286.38M |
| Days Sales Outstanding | 22.52 | 76.29 | 88.15 | 64.41 | 73.34 | 71.24 | 108.75 | 93.83 | 67.58 | 52.94 |
| Inventory | 6.41M | 9M | 13.63M | 12.39M | 20.03M | 26.91M | 35.41M | 40.76M | 44.74M | 64.64M |
| Days Inventory Outstanding | 17.27 | 23.53 | 29.97 | 25.78 | 35.91 | 30.85 | 28.32 | 25.22 | 24.24 | 25.42 |
| Other Current Assets | 1.09M | 59K | 4.6M | 55K | 187K | 228K | 33.63M | 60.52M | 48.63M | 53.86M |
| Total Non-Current Assets | 36.56M | 33.99M | 27.65M | 59.49M | 69.49M | 143.35M | 182.66M | 183.15M | 284.92M | 374.16M |
| Property, Plant & Equipment | 32.29M | 29.67M | 24.34M | 47.01M | 54.75M | 124.53M | 164.33M | 167.75M | 248.19M | 303.48M |
| Fixed Asset Turnover | 6.72x | 7.11x | 10.59x | 6.43x | 7.14x | 5.02x | 4.99x | 6.45x | 6.84x | 7.62x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4.28M | 4.32M | 3.32M | 12.48M | 14.74M | 18.82M | 18.33M | 15.4M | 36.72M | 189.41M |
| Total Assets | 210.68M▲ 0% | 214.61M▲ 1.9% | 268.17M▲ 25.0% | 582.66M▲ 117.3% | 932.15M▲ 60.0% | 1.24B▲ 32.6% | 1.39B▲ 12.8% | 1.44B▲ 3.4% | 1.66B▲ 15.2% | 1.82B▲ 0% |
| Asset Turnover | 1.03x | 0.98x | 0.96x | 0.52x | 0.42x | 0.51x | 0.59x | 0.75x | 1.02x | 1.21x |
| Asset Growth % | -20.57% | 1.87% | 24.96% | 117.27% | 59.98% | 32.65% | 12.78% | 3.39% | 15.19% | 63.5% |
| Total Current Liabilities | 96.42M | 105.56M | 113.98M | 179.87M | 199.05M | 218.96M | 310.5M | 307.27M | 344.05M | 442.02M |
| Accounts Payable | 11.48M | 8.53M | 14.59M | 8.6M | 8.1M | 27.21M | 31.15M | 15M | 34.92M | 46.5M |
| Days Payables Outstanding | 30.9 | 22.3 | 32.06 | 17.9 | 14.51 | 31.19 | 24.92 | 9.28 | 18.92 | 18.71 |
| Short-Term Debt | 49.62M | 50.11M | 50.15M | 50.12M | 50.05M | 50.05M | 80.35M | 80.4M | 80.36M | 80.34M |
| Deferred Revenue (Current) | 574K | 1.42M | 4.13M | 56.02M | 50.13M | 7.4M | 10.78M | 16.61M | 19.75M | 83.66M |
| Other Current Liabilities | 22.39M | 19.04M | 22.68M | 25.5M | 47.74M | 58.15M | 62.96M | 69.1M | 73.39M | 215.95M |
| Current Ratio | 1.81x | 1.71x | 2.11x | 2.91x | 4.33x | 4.99x | 3.90x | 4.10x | 4.00x | 4.00x |
| Quick Ratio | 1.74x | 1.63x | 1.99x | 2.84x | 4.23x | 4.87x | 3.79x | 3.96x | 3.87x | 3.87x |
| Cash Conversion Cycle | 8.89 | 77.52 | 86.05 | 72.29 | 94.73 | 70.9 | 112.16 | 109.77 | 72.9 | 59.65 |
| Total Non-Current Liabilities | 7.79M | 83.64M | 122.03M | 124.07M | 246.86M | 364.23M | 378.23M | 369.1M | 121.27M | 127.28M |
| Long-Term Debt | 0 | 73.06M | 73.36M | 73.66M | 202.49M | 280.39M | 281.65M | 282.94M | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 26.3M | 21.25M | 61.04M | 76.58M | 67.03M | 96.59M | 406.76M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 7.79M | 10.57M | 8.61M | 310K | 320K | 1.48M | 0 | 0 | 0 | 0 |
| Total Liabilities | 104.2M | 189.2M | 236.01M | 303.94M | 445.92M | 583.18M | 688.73M | 676.37M | 465.31M | 569.29M |
| Total Debt | 49.62M | 123.18M | 123.51M | 155.81M | 281.09M | 397.23M | 446.22M | 441.99M | 187.12M | 184.72M |
| Net Debt | 34.37M | 110.56M | 77.1M | 93.89M | 232.43M | 312.85M | -19.87M | -200.1M | -758.47M | -856.72M |
| Debt / Equity | 0.47x | 4.85x | 3.84x | 0.56x | 0.58x | 0.61x | 0.63x | 0.58x | 0.16x | 0.16x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.59x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 2.72x |
| Interest Coverage | -181.03x | -31.81x | -10.94x | -10.88x | -14.34x | -56.37x | -58.06x | -35.31x | -20.80x | -69.90x |
| Total Equity | 106.48M▲ 0% | 25.42M▼ 76.1% | 32.16M▲ 26.5% | 278.71M▲ 766.6% | 486.24M▲ 74.5% | 653.3M▲ 34.4% | 705.74M▲ 8.0% | 765.33M▲ 8.4% | 1.2B▲ 56.2% | 1.25B▲ 0% |
| Equity Growth % | -42.37% | -76.13% | 26.54% | 766.58% | 74.46% | 34.36% | 8.03% | 8.44% | 56.2% | 203.81% |
| Book Value per Share | 2.06 | 0.47 | 0.56 | 4.01 | 6.00 | 7.21 | 7.17 | 6.66 | 9.58 | 9.13 |
| Total Shareholders' Equity | 106.48M | 25.42M | 32.16M | 278.71M | 486.24M | 653.3M | 705.74M | 765.33M | 1.2B | 1.25B |
| Common Stock | 5K | 6K | 7K | 8K | 9K | 10K | 11K | 11K | 12K | 14K |
| Retained Earnings | -345.85M | -446.38M | -574.53M | -699.17M | -929.32M | -1.39B | -1.94B | -2.38B | -2.57B | -2.82B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -725K | -766K | -552K | 919K | 4.26M | -2.29M | -16.36M | -3.08M | -344K | -187K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NTRA Cash Flow Statement
Natera, Inc. (NTRA) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -74.05M | -97.83M | -70.58M | -63.44M | -182.51M | -335.24M | -431.5M | -246.96M | 135.66M | 135.66M |
| Operating CF Margin % | -34.11% | -46.38% | -27.39% | -20.99% | -46.68% | -53.6% | -52.61% | -22.81% | 7.99% | - |
| Operating CF Growth % | -95.74% | -32.1% | 27.85% | 10.11% | -187.67% | -83.68% | -28.72% | 42.77% | 154.93% | 1112% |
| Net Income | -100.33M | -137.63M | -128.15M | -124.83M | -229.74M | -471.72M | -547.8M | -434.8M | -190.43M | -309.19M |
| Depreciation & Amortization | 6.18M | 7.14M | 7.5M | 7.73M | 8.61M | 11.25M | 16.7M | 24.1M | 30.97M | 37.18M |
| Stock-Based Compensation | 10.6M | 11.4M | 14.2M | 28.62M | 50.17M | 115.22M | 152.38M | 191.81M | 274.43M | 333.75M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 7.16M | 1.65M | 8.72M | -2.17M | 27.58M | 55.61M | 30.36M | 19.89M | 18.55M | 14.56M |
| Working Capital Changes | 2.34M | 19.61M | 27.16M | 27.2M | -39.13M | -45.6M | -83.15M | -47.95M | 2.14M | 118M |
| Change in Receivables | -3.96M | 6.32M | -18.09M | 2.42M | -25.83M | -43.51M | -122.31M | -33.9M | -35.88M | 20.5M |
| Change in Inventory | -431K | -3.09M | -4.9M | 917K | -7.47M | -6.88M | -8.5M | -5.35M | -3.98M | -15.92M |
| Change in Payables | 1.26M | 217K | 3.78M | -6.26M | -118K | 19.22M | 5.46M | -15.46M | 13.21M | 14.71M |
| Cash from Investing | 47.03M | 13.78M | -5.16M | -266.35M | -331.46M | -205.19M | 330.34M | 168.5M | 137.62M | -71.73M |
| Capital Expenditures | -23.14M | -9.87M | -3.88M | -4.97M | -19.6M | -41.03M | -47.7M | -39.2M | -66.42M | -88.23M |
| CapEx % of Revenue | 10.66% | 4.68% | 1.51% | 1.64% | 5.01% | 6.56% | 5.82% | 3.62% | 3.91% | - |
| Acquisitions | 0 | 0 | 0 | 9.68M | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -8.56M | 0 | 0 | -10.49M | -12.5M |
| Cash from Financing | 13.18M | 80.37M | 113.72M | 340.77M | 500.85M | 576.19M | 482.64M | 254.46M | 30.2M | 26.03M |
| Debt Issued (Net) | 7M | 75M | 0 | 0 | 199.56M | 0 | 30M | 0 | -82K | -82K |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 2.54M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -287K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.94M |
| Net Change in Cash | -13.84M▲ 0% | -3.67M▲ 73.5% | 37.98M▲ 1135.2% | 10.98M▼ 71.1% | -13.13M▼ 219.6% | 35.76M▲ 372.4% | 381.48M▲ 966.8% | 176M▼ 53.9% | 303.49M▲ 72.4% | 148.59M▲ 0% |
| Free Cash Flow | -97.04M▲ 0% | -106.66M▼ 9.9% | -74.46M▲ 30.2% | -68.41M▲ 8.1% | -202.12M▼ 195.4% | -376.27M▼ 86.2% | -479.2M▼ 27.4% | -286.15M▲ 40.3% | 69.24M▲ 124.2% | 93.56M▲ 0% |
| FCF Margin % | -44.7% | -50.56% | -28.9% | -22.63% | -51.69% | -60.16% | -58.42% | -26.43% | 4.08% | 4.42% |
| FCF Growth % | -112.41% | -9.91% | 30.19% | 8.12% | -195.44% | -86.16% | -27.36% | 40.28% | 124.2% | 381.95% |
| FCF per Share | -1.88 | -1.99 | -1.29 | -0.98 | -2.49 | -4.15 | -4.87 | -2.49 | 0.56 | 0.56 |
| FCF Conversion (FCF/Net Income) | 0.77x | 0.72x | 0.55x | 0.51x | 0.79x | 0.71x | 0.79x | 0.57x | -0.71x | -0.30x |
| Interest Paid | 0 | 3.57M | 7.91M | 12.46M | 3.3M | 7.08M | 8.06M | 11.35M | 7.9M | 2.16M |
| Taxes Paid | 0 | 177K | 332K | 2.15M | 67K | 283K | 549K | 295K | 1.31M | 0 |
NTRA Key Ratios
Natera, Inc. (NTRA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -65.76% | -206.7% | -445.14% | -80.31% | -60.07% | -82.79% | -80.62% | -59.11% | -19.42% | -24.69% |
| Return on Invested Capital (ROIC) | -42.73% | -72.63% | -70.11% | -36.2% | -29.73% | -41.68% | -49.13% | -53.5% | -33.27% | -33.27% |
| Gross Margin | 37.54% | 33.82% | 35.55% | 41.96% | 47.92% | 49.09% | 44.37% | 45.52% | 60.3% | 63.7% |
| Net Margin | -44.12% | -64.62% | -49.74% | -41.29% | -58.76% | -75.42% | -66.79% | -40.16% | -11.22% | -14.61% |
| Debt / Equity | 0.47x | 4.85x | 3.84x | 0.56x | 0.58x | 0.61x | 0.63x | 0.58x | 0.16x | 0.16x |
| Interest Coverage | -181.03x | -31.81x | -10.94x | -10.88x | -14.34x | -56.37x | -58.06x | -35.31x | -20.80x | -69.90x |
| FCF Conversion | 0.77x | 0.72x | 0.55x | 0.51x | 0.79x | 0.71x | 0.79x | 0.57x | -0.71x | -0.30x |
| Revenue Growth | 14.04% | -2.83% | 22.15% | 17.34% | 29.33% | 59.97% | 31.13% | 31.99% | 56.75% | 38.17% |
NTRA SEC Filings & Documents
Natera, Inc. (NTRA) SEC filings — annual & quarterly reports (10-K, 10-Q)
NTRA Frequently Asked Questions
Natera, Inc. (NTRA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Natera, Inc. (NTRA) reported $2.12B in revenue for fiscal year 2024. This represents a 14754% increase from $14.3M in 2012.
Natera, Inc. (NTRA) grew revenue by 56.7% over the past year. This is strong growth.
Natera, Inc. (NTRA) reported a net loss of $309.2M for fiscal year 2024.
Dividend & Returns
Natera, Inc. (NTRA) has a return on equity (ROE) of -19.4%. Negative ROE indicates the company is unprofitable.
Natera, Inc. (NTRA) generated $93.6M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More NTRA
Natera, Inc. (NTRA) financial analysis — history, returns, DCA and operating performance tools
Full NTRA Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates